August 2026

4 medicines lost their last listed patent or exclusivity in August 2026.

1. Aug 13Nuedextadextromethorphan hydrobromide and quinidine sulfate · Otsuka America Pharmaceutical Inc
2. Aug 19Tekturnaaliskiren hemifumarate · Lxo Ireland Designated Activity Co
3. Aug 21Gallium Ga 68 Edotreotidegallium GA-68 edotreotide · Univ Iowa Hosps and Clinics Pet Imaging Center
4. Aug 24Dymistaazelastine hydrochloride and fluticasone propionate · Mylan Specialty LP